Abeona Therapeutics Inc.
Abeona Therapeutics Inc. (ABEO) Revenue
Annual & quarterly revenue history · segment & region breakdown
ABEO · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsAbeona Therapeutics Inc. trailing twelve-month (TTM) revenue is $0.01B, an increase of 0.00% year-over-year from $0.01B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.01B | +$0.01B | — |
| 2024-12-31 | $0.00B | -$0.00B | -100.00% |
| 2023-12-31 | $0.00B | +$0.00B | +147.52% |
| 2022-12-31 | $0.00B | -$0.00B | -52.87% |
| 2021-12-31 | $0.00B | -$0.01B | -70.00% |
| 2020-12-31 | $0.01B | +$0.01B | — |
| 2019-12-31 | $0.00B | -$0.00B | -100.00% |
| 2018-12-31 | $0.00B | +$0.00B | +258.18% |
| 2017-12-31 | $0.00B | -$0.00B | -5.85% |
| 2016-12-31 | $0.00B | -$0.00B | -14.52% |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Abeona Therapeutics Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Abeona Therapeutics Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Abeona Therapeutics Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ABEO revenue · 4 questionsABEO's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 0.00% year-over-year from $0.01B in FY2025.
▸ Source: FMP · Abeona Therapeutics Inc. SEC filings · GAAP · Abeona Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026